Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Group B Streptococcus Disease”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Not applicableWithdrawnNCT02099149
What this trial is testing

Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days

Who this might be right for
Invasive Group B Streptococcus Disease
Novartis
Not applicableUnknownNCT02812576
What this trial is testing

Burden of Invasive Group B Streptococcal Disease in Infants and Resistance Surveillance in China

Who this might be right for
Invasive Group B Streptococcal Disease
Xi'an Jiaotong University 150
Not applicableUnknownNCT04735419
What this trial is testing

Development of a Serocorrelate of Protection Against Invasive Group B Streptococcus Disease

Who this might be right for
Streptococcus Agalactiae Infection
St George's, University of London 400
Not applicableStudy completedNCT01933646
What this trial is testing

Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China

Who this might be right for
Invasive Group B Streptococcal Disease
Novartis Vaccines 10
Not applicableUnknownNCT04653948
What this trial is testing

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Who this might be right for
Group B Streptococcus Carrier in ChildbirthGroup B Streptococcal Infection, Late-OnsetGroup B Streptococcal Infection, Early-Onset+2 more
St George's, University of London 3,423
Early research (Phase 1)Study completedNCT00645346
What this trial is testing

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18- 40 Years of Age

Who this might be right for
Invasive Group B Streptococcus (GBS) Disease
Novartis Vaccines 130
Not applicableUnknownNCT01911572
What this trial is testing

Genetic Susceptibility to Severe Streptococcal Infections

Who this might be right for
Invasive Streptococcal InfectionInvasive Group A Streptococcal DiseaseInvasive Group B Streptococcal Disease+1 more
University of Oxford 200
Not applicableNot Yet RecruitingNCT06896526
What this trial is testing

Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry

Who this might be right for
Invasive Group B Streptococcus DiseaseGroup B StreptococcusGroup B Streptococcal Infection+3 more
Precia Group 10,000
Not applicableUnknownNCT05726006
What this trial is testing

Invasive Group B Streptococcus Disease Burden and Its Antimicrobial Resistance in Malaysia Among Non-pregnant Adults.

Who this might be right for
Invasive InfectionDiabetic FootImmunocompromised Patients+1 more
Universiti Putra Malaysia 133
Not applicableStudy completedNCT06431217
What this trial is testing

Group B Strep Correlates of Protection Study

Who this might be right for
Maternal HealthChild HealthInfectious Diseases
University of Witwatersrand, South Africa 17,842
Not applicableLooking for participantsNCT06833957
What this trial is testing

Preparing for Maternal GBS Vaccine Trials in Africa

Who this might be right for
Group B StreptococcusInvasive Bacterial Diseases (IBD)Maternal Immunization
Barcelona Institute for Global Health 18,100
Not applicableStudy completedNCT01888471
What this trial is testing

Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])

Who this might be right for
Streptococcus Agalactiae
GlaxoSmithKline 3,033
Early research (Phase 1)Study completedNCT00657683
What this trial is testing

A Phase I, Randomized, Single-blind, Controlled, Single Center Study to Evaluate the Safety and Immunogenicity of a Dose Range of a Monovalent Glycoconjugate Antigen Vaccine of Group B Streptococcus in Healthy Women 18-40 Years of Age

Who this might be right for
Invasive Group B Streptococcus (GBS) Disease
Novartis Vaccines 65
Not applicableStudy completedNCT02215226
What this trial is testing

GBS Sero-correlate of Protection

Who this might be right for
Invasive Group B Streptococcus Disease
University of Witwatersrand, South Africa 35,274